SCHEMBL189482

SCHEMBL189482

NC1=CC2CCC1C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8350376 0.97
SCHEMBL15577294 0.83
SCHEMBL146825 0.69
SCHEMBL512358 0.68
SCHEMBL4666280 0.68
SCHEMBL161708 0.68
SCHEMBL2568698 0.68
SCHEMBL220699 0.68
SCHEMBL6715260 0.68
SCHEMBL10826700 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117186403-B Negative photosensitive resin, resin composition, and preparation method and application thereof 明士(北京)新材料开发有限公司 2024-04-02 CN claimed
CN-117186403-A Negative photosensitive resin, resin composition, and preparation method and application thereof 明士(北京)新材料开发有限公司 2023-12-08 CN claimed
EP-2741352-B1 Negative electrode for rechargeable lithium battery, method of preparing the same and rechargeable lithium battery including the same SAMSUNG SDI CO LTD (KR) 2016-11-02 EP claimed
US-9437872-B2 Negative electrode for rechargeable lithium battery, method of preparing the same and rechargeable lithium battery including the same SAMSUNG SDI CO., LTD. (KR) 2016-09-06 US claimed
EP-2741352-A2 Negative electrode for rechargeable lithium battery, method of preparing the same and rechargeable lithium battery including the same Samsung SDI Co., Ltd. (KR) 2014-06-11 EP claimed
US-20140154562-A1 NEGATIVE ELECTRODE FOR RECHARGEABLE LITHIUM BATTERY, METHOD OF PREPARING THE SAME AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2014-06-05 US claimed
EP-1019426-B1 NOVEL A1 ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS UNIV FLORIDA (US) 2003-03-12 EP claimed
EP-0092647-B1 NEW ACTIVE COMPOUNDS IN THE TREATMENT OF ULCERS AND SKIN ALLERGY SYMPTOMS MAGIS FARMACEUTICI S.p.A. (IT) 1987-01-14 EP claimed
EP-0092647-A1 New active compounds in the treatment of ulcers and skin allergy symptoms MAGIS FARMACEUTICI S.p.A. (IT) 1983-11-02 EP claimed
EP-4736995-A1 SEPARATION MEMBRANE, SEPARATION MEMBRANE LAYERED BODY, SEPARATION MODULE OR SEPARATION TOWER, HYDROGEN RECOVERY SYSTEM, AND HYDROGEN SEPARATION AND RECOVERY METHOD Mitsubishi Chemical Corporation (JP) 2026-05-06 EP disclosed
US-20260115671-A1 SEPARATION MEMBRANE, SEPARATION MEMBRANE LAYERED BODY, SEPARATION MODULE OR SEPARATION TOWER, HYDROGEN RECOVERY SYSTEM, AND HYDROGEN SEPARATION AND RECOVERY METHOD MITSUBISHI CHEMICAL CORPORATION (JP) 2026-04-30 US disclosed
EP-4691613-A1 ZEOLITE MEMBRANE COMPOSITE AND METHOD FOR PRODUCING PURIFIED COMPONENT Mitsubishi Chemical Corporation (JP) 2026-02-11 EP disclosed
US-20260022213-A1 HYDROGELS AND METHODS OF USING THE SAME ROWAN UNIVERSITY (US) 2026-01-22 US disclosed
US-20260021454-A1 ZEOLITE MEMBRANE COMPOSITE AND METHOD FOR PRODUCING PURIFIED COMPONENT MITSUBISHI CHEMICAL CORPORATION (JP) 2026-01-22 US disclosed
US-5736528-A CARDIOTONIC AGENTS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 1998-04-07 US disclosed
WO-1997024363-A1 NOVEL A1 ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS UNIVERSITY OF FLORIDA (US) 1997-07-10 WO disclosed
EP-0092647-B1 NEW ACTIVE COMPOUNDS IN THE TREATMENT OF ULCERS AND SKIN ALLERGY SYMPTOMS MAGIS FARMACEUTICI S.p.A. (IT) 1987-01-14 EP disclosed
US-4613596-A ANTAGONISTS FOR HISTAMINE H2 RECEPTORS, ANTIULCER, SKIN DISORDERS MAGIS FARMACEUTRICI S.R.L. (IT) 1986-09-23 US disclosed
EP-0092647-A1 New active compounds in the treatment of ulcers and skin allergy symptoms MAGIS FARMACEUTICI S.p.A. (IT) 1983-11-02 EP disclosed
EP-0092647-A1 New active compounds in the treatment of ulcers and skin allergy symptoms MAGIS FARMACEUTICI S.p.A. (IT) 1983-11-02 EP disclosed